Rakovina Therapeutics Inc.
RKV.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.91M | -5.42M | -3.92M | -2.96M | -2.43M |
| Total Depreciation and Amortization | 383.30K | 384.30K | 385.40K | 392.40K | 395.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 588.60K | 278.50K | 292.90K | 165.20K | 164.10K |
| Change in Net Operating Assets | -116.40K | -579.00K | -222.00K | -392.50K | 56.80K |
| Cash from Operations | -5.06M | -5.33M | -3.46M | -2.79M | -1.81M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 1.35M | 1.35M | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.56M | 6.86M | 4.92M | 4.92M | 2.00M |
| Repurchase of Common Stock | -16.70K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -263.60K | -289.70K | -188.40K | -188.40K | -80.80K |
| Cash from Financing | 5.49M | 5.70M | 3.41M | 3.41M | 1.40M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 429.80K | 370.30K | -52.10K | 617.60K | -415.10K |